肺部化颗粒瘤与有利的和纵向的治疗反应
Suguru Kojima1, Noriyuki Enomoto1,2, Keisuke Morikawa1
1Second Division, Department of Internal Medicine Hamamatsu University School of Medicine Hamamatsu Japan.
Respirology case reports
|April 23, 2025
概括
一种罕见的肺部疾病 - - 肺部化颗粒瘤 - - 通过活检诊断出来. 葡萄糖皮质类药物治疗减少了结节的大小五年,但持续的炎症表明需要更安全的长期治疗.
科学领域:
- 肺部病理学 肺部病理学
- 病理学 病理学 病理学
- 罕见疾病 罕见疾病
背景情况:
- 肺化颗粒瘤 (PHG) 是一种罕见的良性肺部疾病,原因不明.
- 它通常呈现为一个单独的肺结节.
- 诊断通常需要侵入性手术,如肺活检.
研究的目的:
- 报告一个肺部质化颗粒瘤病例.
- 评估治疗PHG的葡萄糖皮质体治疗的长期疗效和安全性.
- 突出了对替代治疗策略的需要.
主要方法:
- 通过肺结节活检证实了PHG的诊断.
- 治疗包括葡萄糖皮质类药物.
- 对治疗反应和疾病进展的监测持续了五年.
主要成果:
- 葡萄糖皮质醇治疗导致肺结节大小的减少.
- 这种治疗有效地控制了这种情况,持续了五年.
- 尽管接受了治疗,但观察到持续的炎症,表明疾病控制不完全.
结论:
- 通过肺结节活检,可以诊断肺质化颗粒瘤.
- 葡萄糖皮质类药物提供短期到中期的疗效,但并不是绝对的治疗方法.
- 对于PHG患者来说,更安全,更有效的长期治疗选择是必要的,以确保持续的生存和生活质量.
更多相关视频
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
11.4K
04:44Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
19.6K
相关概念视频
Pulmonary Tuberculosis V
150
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
150
Pulmonary Tuberculosis II
195
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
195
Pneumonia IV: Management
264
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
264
Pulmonary Tuberculosis III
265
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
265
